4D Molecular Therapeutics (4DMT) is a clinical-stage biopharmaceutical company that is dedicated to inventing and developing innovative products in the field of genetic medicine. Their goal is to unlock the full potential of genetic medicine to treat a wide range of large market diseases. The company utilizes a transformative vector discovery platform called Therapeutic Vector Evolution, which enables them to create customized and proprietary gene delivery vehicles (vectors) for targeted delivery of therapeutic payloads to specific tissue types associated with the underlying disease.

With a focus on bold innovation, 4DMT's product design, development, and manufacturing engine allows them to efficiently create a diverse product pipeline. They are committed to revolutionizing genetic medicines and strive towards developing potential curative therapies. Guided by their core principles of daring to cure, breaking boundaries, achieving beyond oneself, and relentless preparation and execution, 4DMT is led by a team of experienced and visionary leaders from various disciplines.

The company is driven by their unwavering dedication to improving patient lives and realizing the full potential of genetic medicine